High materiality7/10
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer lowers HRMY PT to $70; current price $38.78.
- Target: $70
- Posted price: $38.78
- Analyst firm: Oppenheimer
Key facts
- 01
Target: $70
- 02
Posted price: $38.78
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Andreas Argyrides
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.